Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ReLux-AMD: Rheohemapheresis and Lutein in Non-exudative AMD
2006-001385-16Phase 3Completed
- Sponsor
- Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of lutein in age-related macular degeneration (AMD), sponsored by Ludwig Boltzmann Institut für Retinologie und biomikroskopische Laserchirurgie. Primary endpoint: Visual acuity. Started Apr 2007; status: completed.
02
Drugs
lutein
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on 2006-001385-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001385-16.